PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...of five leading vaccine manufacturers, AstraZeneca plc, BioNTech SE, Johnson & Johnson, Moderna Inc., and Pfizer Inc. It also includes for the first time an assessment of the two largest Chinese vaccine producers, China National Pharmaceutical Group Co., Ltd. (Sinopharm) and Sinovac Biotech Ltd. (Sinovac).
more
DEPRESSION AND ANXIETY 27 : 390–403 (2010
BMJ Global Health2020;5:e002786. doi:10.1136/bmjgh-2020-002786
Over the past 50 years, dengue has spread from nine to over a hundred countries, making it the most rapidly spreading vector-borne disease. Yet, dengue continues to have a low profile among policy-makers and donors and does not receive the media attention it deserves. While there is no vaccine or cu...re for dengue, it can be managed and prevented. We need a renewed commitment to integrated programming that includes improved management and diagnosis, increased awareness and community participation in controlling the vector and enhanced environmental sanitation
more
Principles and Target Product Criteria. Roadmap January 12, 2015
Joint Stakeholder Submission
Accessed: 29.09.2019
Independent Monitoring Board of the Global Polio Eradication Initiative (Twelfth Report: October 2015)
Full Length Research Paper
Received 23 March, 2015; Accepted 5 August, 2015
Vol.7(9), pp. 204-213, September, 2015 DOI: 10.5897/IJSA2015.0604
Article Number: F0D0DDC54848
ISSN 2006- 988x